Formic Acid

Formic Acid

SCHEMBL7370577

CC(C)(C)OC(=O)NC[C@H](N)C(=O)O.O=CO

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
GAA P10253 1/20 0.47
KMT2A Q03164 1/20 0.47
GFPT1 Q06210 1/20 0.46
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
TDP1 Q9NUW8 1/20 0.39
SYK P43405 1/20 0.39
CASR P41180 5/20 0.38
CTSK P43235 6/20 0.38
CTSS P25774 3/20 0.38
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38
SLC7A5 Q01650 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL994583 0.93 MEN1 (0.53) MEN1GAAKMT2AGFPT1MAOA
SCHEMBL994584 0.93 MEN1 (0.53) MEN1GAAKMT2AGFPT1MAOA
SCHEMBL997508 0.93 MEN1 (0.53) MEN1GAAKMT2AGFPT1MAOA
Hydrochloric Acid SCHEMBL2680968 0.92 MEN1 (0.51) MEN1GAAKMT2AGFPT1MAOA
Hydrochloric Acid SCHEMBL668972 0.92 MEN1 (0.51) MEN1GAAKMT2AGFPT1MAOA
Hydrochloric Acid SCHEMBL2681229 0.92 MEN1 (0.51) MEN1GAAKMT2AGFPT1MAOA
Chloromethane SCHEMBL17911911 0.92 MEN1 (0.51) MEN1GAAKMT2AGFPT1MAOA
SCHEMBL23455458 0.83 MEN1 (0.46) MEN1GAAKMT2AGFPT1MAOA
SCHEMBL23455605 0.83 MEN1 (0.46) MEN1GAAKMT2AGFPT1MAOA
SCHEMBL13365413 0.81 MEN1 (0.47) MEN1GAAKMT2AGFPT1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1049693-A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS $g(a) v?$g(b) 3? ANTAGONISTS Du Pont Pharmaceuticals Company (US) 2000-11-08 EP disclosed
WO-1999026945-A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS αvβ3 ANTAGONISTS DU PONT PHARMACEUTICALS COMPANY (US) 1999-06-03 WO disclosed